Zylox-Tonbridge Medical Technology Co., Ltd. Class H(HK:2190)
HK$18.17-0.11 (-0.60%)
HK:2190
Zylox-Tonbridge Medical Technology Co., Ltd. Class H financials statements
HK$18.17
At close:-0.11 (-0.60%)
Want to see HK:2190 full AI Analyst Report?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190) Income Statement
3 Followers
Zylox-Tonbridge Medical Technology Co., Ltd. Class H Income Statement
Last quarter (Q2 2026), Zylox-Tonbridge Medical Technology Co., Ltd. Class H's total revenue was ¥632.04M, an increase of 72.69% from the same quarter last year. In Q2, Zylox-Tonbridge Medical Technology Co., Ltd. Class H's net income was ¥181.71M. See Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 1.06B | ¥ 782.48M | ¥ 527.75M | ¥ 334.09M | ¥ 177.91M | |
| ¥ 762.92M | ¥ 559.89M | ¥ 384.99M | ¥ 252.67M | ¥ 131.88M | |
| ¥ 562.65M | ¥ 499.02M | ¥ 541.51M | ¥ 474.86M | ¥ 349.94M | |
| Depreciation and Amortization | ¥ 37.27M | ¥ 37.85M | ¥ 35.88M | ¥ 26.27M | ¥ 13.38M |
| ¥ 236.08M | ¥ 74.03M | ¥ -41.60M | ¥ -86.56M | ¥ -204.78M | |
| ¥ 196.64M | ¥ 60.91M | ¥ -156.52M | ¥ -208.40M | ¥ -212.48M | |
| ¥ 33.97M | ¥ 39.34M | ¥ 77.79M | ¥ 94.84M | ¥ 12.79M | |
| ¥ 230.61M | ¥ 100.26M | ¥ -78.73M | ¥ -113.56M | ¥ -199.69M | |
| ¥ 244.37M | ¥ 100.26M | ¥ -78.73M | ¥ -113.56M | ¥ -199.69M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.76 | ¥ 0.31 | ¥ -0.24 | ¥ -0.34 | ¥ -0.68 |
| Diluted EPS | ¥ 0.76 | ¥ 0.31 | ¥ -0.24 | ¥ -0.34 | ¥ -0.68 |
| Weighted Average Shares Outstanding | 323.58M | 323.32M | 328.71M | 330.39M | 294.60M |
| Weighted Average Shares Outstanding (Diluted) | 323.60M | 327.99M | 328.71M | 330.39M | 294.60M |
Currency in CNY

